Phase II evaluation of dibromodulcitol, ICRF-159, and maytansine for sarcomas
- 1 August 1982
- journal article
- research article
- Published by Wolters Kluwer Health in American Journal of Clinical Oncology
- Vol. 5 (4), 417-420
- https://doi.org/10.1097/00000421-198208000-00012